A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of BupiVacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal.

Trial Profile

A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of BupiVacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2014

At a glance

  • Drugs Bupivacaine (Primary) ; Ketorolac; Morphine; Nonsteroidal anti-inflammatories
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms IMPROVE-Ileostomy Reversal
  • Sponsors Pacira Pharmaceuticals
  • Most Recent Events

    • 26 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Feb 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
    • 02 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top